Prospective study about 45 cases of disseminated intravascular coagulation

##plugins.themes.academic_pro.article.sidebar##

Published Oct 5, 2012
Download
pdf
Vol. 90 No. 10 (2012): Issue Oct 2012

##plugins.themes.academic_pro.article.main##

Nabil Mathlouthi
Belhassen Ben Ayed
Habib Amouri
Mounir Bouaziz
Kamel Kolsi
Mohamed Ayadi
Kaies Chaabene
Mohamed Dhouib
Khaled Trabelsi
Sahbi Kbaili
Mohamed Guermazi

Abstract

Background: Disseminated intravascular coagulation (DIC) in obstetric disorders is a severe complication.
Aim: To study the frequency and means of diagnosis of DIC and the therapeutic care and maternal morbidity induced.
Methods: Monocentric, prospective and descriptive study about 45 cases of intravascular coagulation in an obstetrical service collected at the University Hospital of Obstetrics and Gynecology Hedi Chaker of Sfax over a period ranging from June 2007 to June 2010. All the pregnant patients who have given birth beyond 28 weeks and have presented a DIC were selected for this study.
Results: The mean age of patients was 31.4 years. The mean parity was 2.6. The main diseases during pregnancy were: severe preeclampsia (22.2%), diabetes (28.8%), intrauterine fetal death (17.7%), previa placenta (8.8%). The main causes of DIC were: uterine atony (44.4%), abruptio placenta (22.2%), Hellp syndrome (11.1%) and uterine rupture (6, 6%). The lowest rate of platelets was 21000/mm3. The fibrinogen level was <0.5 g in 40% of cases. Despite reanimation and transfusion with blood products, surgical treatment was necessary in 77.7% of cases. All the patients were transferred in intensive care unit with an average stay of about three days. No maternal death was reported.
Conclusion: DIC is a frequent complication of many obstetrical diseases. The treatment is urgent. It requires first to the cause and the shock by massive transfusions of packed red blood cells, fresh frozen plasma, and platelets, associated with antifibrinolytic drugs, if necessary.

Keywords:

Post partum haemorrhage; disseminated intravascular coagulation; reanimation; transfusion.

##plugins.themes.academic_pro.article.details##

References

  1. A. Rochette, Y. Jullien, J. DU Cailar. Coagulation intravasculaire disséminée. Etude rétrospective de 14 cas obstétricaux aigus. Ann. Fr. Anesth. Réa 1983; 2: 259-65.
  2. Kor-anantakul O, Lekhakula A. Overt disseminated intravascular coagulation in obstetric patients. J Med Assoc Thai. 2007; 90:857-64.
  3. I. Elalamy. Coagulation intravasculaire disséminée. Encyclopédie Médico-chirurgicale - Ann. Fr. Anesth. Réa 2006 ; 2: 259-65.
  4. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a “prima ballerina”. Thromb Haemost 1995; 74: 7-17.
  5. Jecko Thachil, Cheng-Hock Toh. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Reviews 2009 ; 23 : 167-76.
  6. G. Tramoni, C. Boisson, L. Gamerre et al. Embolie de liquide amniotique : mise au point. Ann Fr Anes Réa 2006; 25 : 599-604.
  7. B. Jude, S. Susen. Coagulation intravasculaire disséminée en réanimation : utilisation des inhibiteurs de la voie du facteur tissulaire. Réanimation 2002; 11 : 638-44
  8. J. Kramer, H.M. Otten, M. Levi, H. ten Cate. The association of disseminated intravascular coagulation with specific diseases. Réanimation 2002 ; 11 : 575-83.
  9. Sibaï B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;36:785-99
  10. Y. Ozier Caractéristiques évolutives des CIVD au cours de la grossesse, du sepsis, des traumatismes graves, et de l'insuffisance hépatique. Réanimation 2002 ; 11 : 618-28
  11. Pritchard JA. Fetal death in utero. Obstet Gynecol 1959;14:573-80.
  12. David R. Hall, MBChB, MMed. Abruptio Placentae and Disseminated Intravascular Coagulopathy. Semin Perinatol 2009; 33:189-95.
  13. M. Nayama, D. Tamakloé-Azamesu, M. Garba, N et al. Hématome rétro-placentaire. Prise en charge dans une maternité de référence du Niger. Étude prospective à propos de 118 cas sur un an. Gynécol Obstét Fertil 2007 ; 35 : 975-81.
  14. Baxter JK, Weinstein L. HELLP syndrome: The state of the art. Obstet Gynecol Surv 2004;59:838-45
  15. G. Beucher, T. Simonet, M. Dreyfus. Prise en charge du HELLP syndrome. Gynécol Obstét Fertil 2008 ; 36 : 1175-90.
  16. Sibaï BM, Ramadan MK, Usta I et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6
  17. P.E. Bollaert, D. Annane, H. Aube, J.P et al. Coagulations intravasculaires disséminées (CIVD) en réanimation : définition, classification et traitement (à l'exception des cancers et hémopathies malignes). Réanimation 2002 ; 11 : 567-74
  18. N. Lerolle, D. Borgel, JL. Diehl. Approche critique des critères diagnostiques de coagulation intravasculaire disséminée. Réanimation 2008 ; 17 : 348-54.
  19. Toh CH, Downey C. Back to the future: testing in disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2005;16:535-42
  20. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:385-96
  21. M. Levi. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thrombosis Research 2009; 123: 63-64
  22. Levi M, ten Cate H, van der Poll T. Disseminated intravascular coagulation: state of the art. Thromb Haemost 1999; 82:695-705
  23. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
  24. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114: 409-14.
  25. Nieuwenhuizen W. A reference material for harmonisation of Ddimer assays. Thromb Haemost 1997;77:1031-3.
  26. M. Fouassier, F. Quainon, A.F. Serre, B. Souweine Traitement substitutif symptomatique des CIVD (à l'exclusion des antithrombine et protéine C). Réanimation 2002 ; 11 : 629-37
  27. M. Bahloul, H. Dammak, N. Khlaf-Bouaziz, K et al. Stéatose hépatique aiguë gravidique. À propos de 22 cas. Gynécol Obstét Fertil 2006 ; 34 : 597-606
  28. Pelage JP, Limot O. Place actuelle de l'embolisation artérielle dans la prise en charge des hémorragies graves du postpartum immédiat. Gynecol Obstet Fertil 2008;36:714-20.
  29. M. Koné, R. Konan Blé, K. Séni, et al. Ligature des artères iliaques internes face aux hémorragies obstétricales graves en milieu africain. Gynécol Obstét Fertil 2009 ; 37 : 476-80.
  30. Y. Blanloeil. Prise en charge thérapeutique de la coagulation intravasculaire disséminée (CIVD). Actualités. Ann Fr Anest Réan 2005; 24: 444-48.
  31. Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004;124:567-76
  32. G. Andreu, J. Vasse, R. Tardivel, G. Semana. Transfusion de plaquettes : produits, indications, dose, seuil, efficacité. Trans Clin Biol 2009 ; 16 : 118-33.
  33. A. Brice, U. Hilbert, S. Roger-Christoph, et al. Intérêt du facteur VII activé recombinant dans l'hémorragie de la délivrance sévère réfractaire à la prise en charge conservatrice conventionnelle. Ann Fr Anes Réan 2004 ;14 : 1084-88.
  34. C. Boyer-Neumann, FJ. Mercier, A. Veyradier. Facteur VII active recombinant (NovoSeven®) : indications et limites. Réanimation 2006 ;15 : 576-83.
  35. J.F. Dhainaut, J. Charpentier. CIVD et défaillance d'organes : arguments expérimentaux et cliniques. Réanimation 2002 ; 11 : 599-607.